Monday August 24, 2020
Age 40 or 50? A randomized, controlled trial at 23 breast screening units in Great Britain aimed to estimate the effect of mammographic screening at ages 40-48 on breast cancer mortality. The findings have just been published in The Lancet/Oncology: Effect of mammographic screening from age 40 years on breast cancer mortality: final results of a randomized, controlled trial.
Did you know we have made over 200 updates to DB-I website content so far this year? These include our updated and expanded table, Summary of Cancer Detection Rates by Screening Methods (European visitors, click HERE). It is a popular resource and compares, by modality and breast density category, the added cancer detection rate, the impact on false positive rate, and details the types of cancers seen.